Editor's choice

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, Claire Williams, Iryna Schlackow, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Richard Parnell, Jane Armitage, Alastair Gray, John Simes, Colin Baigent

Heart Nov 2024, 110 (21) 1277-1285; DOI: 10.1136/heartjnl-2024-324052
Associations between circulating proteins and cardiometabolic diseases: a systematic review and meta-analysis of observational and Mendelian randomisation studies
Ting Wu, Yalei Ke, Yingtao Li, Zhiyu Wu, Jun Lv, Canqing Yu, Dianjianyi Sun, Pang Yao, Christiana Kartsonaki, Zhengming Chen, Liming Li, Yuanjie Pang

Heart Oct 2024, 110 (20) 1208-1215; DOI: 10.1136/heartjnl-2024-324050
Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial
Harlan M Krumholz, James A de Lemos, Naveed Sattar, Bruno Linetzky, Palash Sharma, Casey J Mast, Nadia N Ahmad, Mathijs C Bunck, Adam Stefanski

Heart Oct 2024, 110 (19) 1165-1171; DOI: 10.1136/heartjnl-2024-324170
Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study
Valentino Collini, Luca Siega Vignut, Federico Angriman, Gioia Braidotti, Marzia De Biasio, Massimo Imazio

Heart Sep 2024, 110 (18) 1139-1144; DOI: 10.1136/heartjnl-2024-324214
Sudden cardiac arrest in patients with cancer in the general population: insights from the Paris-SDEC registry
Orianne Weizman, Assié Eslami, Wulfran Bougouin, Frankie Beganton, Lionel Lamhaut, Daniel Jost, Florence Dumas, Alain Cariou, Eloi Marijon, Xavier Jouven, Mariana Mirabel

Heart Aug 2024, 110 (16) 1022-1029; DOI: 10.1136/heartjnl-2024-324137
Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy
Niccolo Maurizi, Albina Nowak, Christiane Gruner, Mehdi Namdar, Christian Schmied, Alessandra Pia Porretta, Guillaume Barbey, Veronique Monzambani, Pierre Monney, Frédéric Barbey

Heart Aug 2024, 110 (15) 997-1004; DOI: 10.1136/heartjnl-2024-323975
Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)
Fatemeh Malekzadeh, Abdullah Gandomkar, Hossein Poustchi, Arash Etemadi, Gholamreza Roshandel, Armin Attar, Firoozeh Abtahi, Shahrokh Sadeghi Boogar, Vahid Mohammadkarimi, Mohammad Reza Fattahi, Abbas Mohagheghi, Reza Malekzadeh, Sadaf G Sepanlou

Heart Jul 2024, 110 (14) 940-946; DOI: 10.1136/heartjnl-2023-323614
Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study
Joseph James Cuthbert, Ireneous Soyiri, Stephanie Jayne Lomax, John Turgoose, Ahmet Fuat, Judith Cohen, Andrew L Clark

Heart Jun 2024, 110 (12) 854-862; DOI: 10.1136/heartjnl-2023-323577
Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis
Samuel Heuts, Andrea Gabrio, Leo Veenstra, Bart Maesen, Suzanne Kats, Jos G Maessen, Antony S Walton, Shane Nanayakkara, Alexandra J Lansky, Arnoud W J van 't Hof, Pieter A Vriesendorp

Heart Jun 2024, 110 (11) 757-765; DOI: 10.1136/heartjnl-2023-323359
Efficacy and safety of colchicine for the treatment of myopericarditis
Valentino Collini, Maria De Martino, Alessandro Andreis, Marzia De Biasio, Francesca Gaspard, Elena Paneva, Mariacristina Tomat, Gaetano Maria Deferrari, Miriam Isola, Massimo Imazio

Heart May 2024, 110 (10) 735-739; DOI: 10.1136/heartjnl-2023-323484

Main menu

Editor's choice

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Editor's choice

Pages